Merck & Co (MRK) Akcija Цена
Merck & Co Цена
Prihod je rastao 5,7 % godišnje u poslednjih 19 godina na 64,93 Млрд USD. Zarada po akciji rasla je 7,0 % godišnje u poslednjih 19 godina. neto marža kompanije Merck & Co sada iznosi 28,1 %, porasla sa 26,8 % pre nekoliko godina. Merck & Co trenutno nudi dividendni prinos od oko 2,27 %. Odnos isplate je oko 45 % dobiti. Dividenda je rasla 4,1 % godišnje u poslednjih 19 godina. Medijana analitičke ciljane cene je 144,00 USD, odnosno ispod trenutnu cenu za 0,5 %. Od 36 analitičara 26 preporučuje kupovinu — ukupni konsenzus je Kupi.
Cena akcije Merck & Co
Pristupite ovim podacima preko Eulerpool API-ja
100.000 zahteva/mes. besplatno · bez kartice
Merck & Co poslovni model i analiza akcije
Često postavljana pitanja o akciji Merck & Co
The business model of Merck & Co Inc is centered around the development, manufacturing, and marketing of innovative pharmaceutical products and vaccines. Merck's primary aim is to improve and save lives by addressing unmet medical needs. Through rigorous research and development, the company focuses on discovering novel therapies and delivering them to patients worldwide. Merck operates across various therapeutic areas, including oncology, infectious diseases, vaccines, cardiovascular health, and more. By combining scientific expertise with a strong commitment to patients and healthcare professionals, Merck continually strives to advance medical science and make a positive impact on global health.
Merck & Co Inc is primarily active in the pharmaceutical and healthcare industries.
The main competitors of Merck & Co Inc in the market are Johnson & Johnson, Pfizer Inc, Novartis AG, and Bristol-Myers Squibb Company.
Merck & Co Inc is a renowned pharmaceutical company with a rich history and notable background. Established in 1891, Merck & Co Inc has been dedicated to enhancing global health and improving people's lives. The company has evolved into one of the leading players in the pharmaceutical industry, specializing in research, development, and manufacturing of innovative medications and vaccines. Merck & Co Inc has proactively contributed to medical advancements, from pioneering treatments for diseases like HIV/AIDS to addressing various health challenges. With a commitment to scientific excellence and patient well-being, Merck & Co Inc continues to shape the future of healthcare worldwide.
Merck & Co Inc, a leading pharmaceutical company, has achieved significant milestones throughout its history. The company's notable achievements include the development and launch of groundbreaking drugs like Gardasil, a vaccine for preventing cervical cancer, and Keytruda, an innovative immunotherapy for treating various types of cancer. Merck & Co Inc has also contributed to medical advancements with its research and development efforts, resulting in breakthroughs in areas such as HIV/AIDS treatment and vaccines. The company's commitment to improving global health has resulted in partnerships and initiatives aimed at tackling diseases like malaria and Ebola. Merck & Co Inc continues to make strides in the pharmaceutical industry, focusing on innovative solutions for unmet medical needs.
Merck & Co Inc is primarily present in several countries and regions across the world. The company has a strong global presence, with operations in the United States, Europe, Asia-Pacific, Latin America, and Africa. Merck & Co Inc has established a significant presence in key markets such as the United States, Germany, Japan, China, and Brazil. With its wide international footprint, Merck & Co Inc is committed to delivering its innovative healthcare solutions to patients and healthcare professionals worldwide.
Merck & Co Inc represents a strong commitment to scientific innovation, integrity, and improving global health. As a leading pharmaceutical company, Merck aims to discover, develop, and provide high-quality healthcare solutions. The company's corporate philosophy revolves around putting patients first, valuing diversity and inclusion, and taking responsibility for environmental sustainability. Merck is dedicated to delivering innovative medicines and vaccines, ensuring affordability and access for patients worldwide. With a focus on research, collaboration, and ethical business practices, Merck strives to make a positive impact on society and enhance the well-being of individuals around the globe.
Analitičari trenutno postavljaju prosečnu ciljanu cenu 140,42 USD za akciju Merck & Co (medijana: 144,00 USD), što znači -3,2 % u odnosu na poslednju cenu. Konsenzus se zasniva na 36 ocena.
36 analitičara trenutno ocenjuje akciju Merck & Co: 26 preporučuje kupovinu, 10 držanje i 0 prodaju. Za 2026 analitičari očekuju da Merck & Co ostvari prihod 67,06 Млрд USD i zaradu po akciji 2,68 USD.
Po trenutnom kursu akcija Merck & Co kotira 128,94 EUR (144,74 USD).
Akcija Merck & Co (MRK) kotira na 11 berze, uključujući: NYSE (MRK), London (0QAH.L), SIX (Zürich) (MRK1.SW), XETRA (6MK.DE), Frankfurt (6MK.F), München (6MK.MU), Düsseldorf (6MK.DU), Hamburg (6MK.HM).
Merck & Co Inc is one of the leading global pharmaceutical companies focused on the discovery, development, and marketing of drugs, vaccines, and biologics for a variety of diseases and disorders. The company is headquartered in Kenilworth, New Jersey and operates worldwide in over 140 countries.
očekivana prihod od Merck & Co je 67,06 Млрд USD. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.
očekivana dobit od Merck & Co je 6,68 Млрд USD. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.
Odnos cene i zarade (KGV) za Merck & Co je trenutno 53,94. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Merck & Co.
Odnos cene i prihoda (KUV) za Merck & Co je trenutno 5,37. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Merck & Co.
Eulpool score kvaliteta za Merck & Co je 6/10.
ISIN za Merck & Co je US58933Y1055. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.
WKN za Merck & Co je A0YD8Q. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.
Ticker za Merck & Co je MRK. Simbol tikera se koristi za trgovinu akcijama Merck & Co na berzanskom tržištu.
Merck & Co акција
Merck & Co Peer grupa
Merck & Co Тикер
Merck & Co FIGI
Sve ključne metrke i detaljne analize Merck & Co u dubinskoj analizi
Naša analiza akcija za akciju Merck & Co uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Merck & Co. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: